Reprieve Cardiovascular, Inc.
medical devices
About
Decongestion treatment for patients presenting with Acute Decompensated Heart Failure (ADHF) is highly variable and unpredictable, resulting in suboptimal fluid removal, extended hospital stays (~4.9 days), and high-cost burden. Reprieve is bringing intelligence to decongestion management to safely accelerate fluid removal for every heart failure patient. Utilization of Reprieve as frontline therapy management will standardize the algorithm of care and bring predictability and efficiency to acute heart failure management.
Keywords
medical equipment manufacturingmedical deviceshospital & health care
Company Information
- Employees50
Location
459 Fortune Blvd, Milford, Massachusetts, United States, 01757